Policy Brief (Issue 16): Would a rotavirus vaccination program for children under 5 years be cost-effective for Bhutan?
Policy Brief (Issue 15): Should high-cost bevacizumab be used for metastatic-colorectal cancer (mCRC) treatment in JKN in Indonesia?
PolicyBrief (Issue 14): Cetuximab as an adjuvant therapy for metastatic colorectal cancer (mCRC): Does the high cost outweigh the benefit for saving patient’s life?
Research Report: Quality standards for health promotion and disease prevention services in Thailand: phase II
Research report: Cost-Utility Analysis of Bortezomib, Thalidomide and Lenalidomide for Relapsed/Refractory Multiple Myeloma Treatment
Utilisation of evidence from Thailand’s National Health Examination Survey in policy development: finding the weakest link
Policy Brief and Working Paper: Conducive Factors to the Development of Health Technology Assessment in Asia